Over 350 Total Lots Up For Auction at Two Locations - NY 03/21, FL 03/22

Proton Therapy

UK researchers launch brain cancer study comparing proton to photon therapy
Seeking to better understand treatment efficacy
Study shows US proton therapy utilization increasing for complex cancers beyond prostate
Breast, and head and neck cancers are increasingly being treated with protons
Marie by Leo Cancer Care
Award-winning, comprehensive solution for upright particle therapy
Product Showcase Sponsored
spacer
KUMC and IBA to explore tissue sparing effects of ConformalFLASH therapy in preclinical trial
Combines ultrahigh dose rates with Bragg Peak proton properties
Mass General to pay IBA $80 to $100 million to fully restore proton therapy system
The ProteusPLUS at the Francis H. Burr Proton Therapy Center has been in use since 2001
Particle therapy at ASTRO 2023: Insights from Dr. Joern Meissner
Assessing the state of the proton market and its biggest players
Shorter proton therapy schedule for breast cancer still effective: study
Mayo researchers seek to reduce course schedule to three weeks
In a first for Switzerland, researchers treat esophageal cancer with proton therapy
Part of trial comparing side effects to those in radiotherapy
Montecito Medical, Sable Investments acquires Tennessee proton facility
The Tennessee Oncology Proton Center opened in 2018
Real-time MR could make proton therapy more precise
Researchers observe treatment beam using MR during proton irradiation
IBA partners with Belgian researchers to investigate normal tissue toxicity reduction with FLASH proton therapy
First preclinical trial to study FLASH proton therapy in clinical setting
RaySearch to integrate with B dot Medical's ultra-compact proton therapy system
System is small enough to fit inside existing hospitals
Proton therapy yields long-term neurological advantages for children with rare brain tumor
First longitudinal proton therapy study for children with craniopharyngioma
The cost-value argument for expanding proton therapy coverage
What payers may overlook when weighing the cost of proton treatment
The NAPT's National Proton Conference is almost here
Q&A with Jennifer Maggiore, NAPT executive director, and Dr. Elizabeth Nichols, Maryland Proton Treatment Center radiation oncologist

Feature Stories

The cost-value argument for expanding proton therapy coverage

What payers may overlook when weighing the cost of proton treatment

The cost-value argument for expanding proton therapy coverage

What payers may overlook when weighing the cost of proton treatment

Pursuing lower costs and greater access to proton therapy

Innovations are expanding proton's reach, accessibility, and affordability

Pursuing lower costs and greater access to proton therapy

Innovations are expanding proton's reach, accessibility, and affordability

Pediatric proton treatment in the age of COVID

What Is being done to ensure children have access to the best possible outcomes?